首页> 外文期刊>British Journal of Radiology >Consideration of the likely benefit from implementation of prostate image-guided radiotherapy using current margin sizes: A radiobiological analysis
【24h】

Consideration of the likely benefit from implementation of prostate image-guided radiotherapy using current margin sizes: A radiobiological analysis

机译:考虑使用当前切缘大小实施前列腺影像引导放射治疗可能带来的益处:放射生物学分析

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To estimate the benefit of introduction of image-guided radiotherapy (IGRT) to prostate radiotherapy practice with current clinical target volume-planning target volume (PTV) margins of 5-10 mm. Methods: Systematic error data collected from 50 patients were used together with a random error of σ=3.0 mm to model non-IGRT treatment. IGRT was modelled with residual errors of Σ=σ=1.5 mm. Population tumour control probability (TCP pop) was calculated for two three-dimensional conformal radiotherapy techniques: two-phase and concomitant boost. Treatment volumes and dose prescriptions were ostensibly the same. The relative field sizes of the treatment techniques, distribution of systematic errors and correlations between movement axes were examined. Results: The differences in TCP pop between the IGRT and non-IGRT regimes were 0.3% for the two-phase and 1.5% for the concomitant boost techniques. A 2-phase plan, in each phase of which the 95% isodose conformed to its respective PTV, required fields that were 3.5 mm larger than those required for the concomitant boost plan. Despite the larger field sizes, the TCP (without IGRT) in the two-phase plan was only 1.7% higher than the TCP in the concomitant boost plan. The deviation of craniocaudal systematic errors (p=0.02) from a normal distribution, and the correlation of translations in the craniocaudal and anteroposterior directions (p0.0001) were statistically significant. Conclusions: The expected population benefit of IGRT for the modelled situation was too small to be detected by a clinical trial of reasonable size, although there was a significant benefit to individual patients. For IGRT to have an observable population benefit, the trial would need to use smaller margins than those used in this study. Concomitant treatment techniques permit smaller fields and tighter conformality than two phases planned separately.
机译:目的:评估将影像引导放射疗法(IGRT)引入前列腺放射治疗实践中的益处,当前临床目标体积规划目标体积(PTV)边缘为5-10毫米。方法:使用从50例患者中收集的系统误差数据以及σ= 3.0 mm的随机误差来模拟非IGRT治疗。对IGRT建模时,残留误差为Σ=σ= 1.5 mm。计算了两种三维共形放射治疗技术的人口肿瘤控制概率(TCP pop):两阶段和伴随增强。表面上,治疗量和剂量处方是相同的。检查了处理技术的相对场大小,系统误差的分布以及运动轴之间的相关性。结果:IGRT和非IGRT方案之间的TCP pop差异对于两阶段是0.3%,对于伴随的升压技术是1.5%。一个两阶段计划,其每个阶段中95%的等剂量剂量均符合其各自的PTV,其要求的视野比伴随的提升计划所需的视野大3.5毫米。尽管有更大的字段,但两阶段计划中的TCP(没有IGRT)仅比伴随的提升计划中的TCP高1.7%。颅尾神经系统误差(p = 0.02)与正态分布的偏差以及颅尾和前后方向的平移相关性(p <0.0001)具有统计学意义。结论:IGRT在模拟情况下的预期人群收益太小,无法通过合理规模的临床试验检测到,尽管对单个患者有显着收益。为了使IGRT具有可观察到的人口利益,该试验将需要使用比本研究中使用的利润更小的利润率。与单独计划的两个阶段相比,伴随的处理技术允许更小的范围和更严格的保形性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号